HIV Vaccine Research and Development - Central Nervous System Studies

HIV 疫苗研究与开发 - 中枢神经系统研究

• 批准号: 10261699
• 负责人: JULIE AKE
• 金额: $ 95万
• 依托单位: NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10261699
• 关键词: AIDS/HIV problem; Acquired Immunodeficiency Syndrome; Acute; Africa; Area; Basic Science; Clinical Research; Developing Countries; Epidemic; HIV; HIV Infections; HIV vaccine; Infection; International; Medical Research; Military Personnel; National Institute of Allergy and Infectious Disease; Nervous system structure; Neuraxis; Neurologic; Outcome; Plasma; Population; Research; Research Institute; Thailand; Vaccines; Viral; cohort; high risk; nerve injury; neuroAIDS; neuroinflammation; preclinical development; programs; research and development; response; working group

The NIAID Division of AIDS and the U.S. Military HIV Research Program (MHRP), Walter Reed Army Institute of Research (WRAIR), U.S. Army Medical Research and Development Command (MRDC) remain committed to the common objective of developing a safe and effective vaccine for HIV/AIDS. The Agencies recognize the potential utility of an HIV/AIDS vaccine in stopping the global HIV/AIDS epidemic and the need to conduct and support basic science, preclinical development, and both vaccine and non-vaccine clinical research in developing countries where the epidemic is most prevalent.

NIAID AIDS和美国军事艾滋病毒研究计划（MHRP），沃尔特·里德陆军研究所（WRAIR），美国陆军医学研发司令部（MRDC）仍然致力于开发安全有效的艾滋病毒/艾滋病疫苗的共同目标。这些机构认识到艾滋病毒/艾滋病疫苗在阻止全球艾滋病毒/艾滋病流行中的潜在效用，以及在流行病最为普遍的发展中国家进行和支持基础科学，临床前发展以及疫苗和非疫苗的临床研究的需求。